SUPRATHEL
Commercial- Indications
- Burns, Wounds
Company intelligence / Profile preview
PolyMedics Innovations’ lead products SUPRATHEL® and SUPRA SDRM® are clinically proven synthetic wound dressings for burns and difficult-to-heal wounds. These products have demonstrated efficacy in speeding healing and reducing pain in thousands of patients worldwide. The company’s technologies are available in over 40 countries and have been used on more than 250,000 patients. Clinical evidence includes randomized studies as well as prospective non-controlled trials and case series.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PolyMedics Innovations.